Jackie Garlich, OD, FAAO
Link has been copied to your clipboard.
Subscribe to 20/20 Glance for a weekly optometry headline summary in your inbox or view the archives.
Dexycu received FDA approval last week. It’s a sustained-release one-time injection of dexamethasone in the anterior chamber after cataract surgery. This gives an alternative to topical steroid drops following cataract surgery. (via)
Subscribe to 20/20 Glance for a weekly optometry headline summary in your inbox.
Most Popular on Modern Optometry
The Four Stages of Diabetic Retinopathy
Cecelia Koetting, OD, FAAO
What’s New in Contact Lenses?
Ryan Corte, OD
When to Refer to a Neuro-Optometrist
Tanya Polec, OD, FCOVD
The Future of Optometry in America
Richard C. Edlow, OD